BridgeBio Pharma BBIO Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's operating lease ROU assets?
- BridgeBio Pharma (BBIO) reported operating lease ROU assets of $17.23M in Q1 2026.
- How has BridgeBio Pharma's operating lease ROU assets changed year-over-year?
- BridgeBio Pharma's operating lease ROU assets increased by 140.4% year-over-year, from $7.17M to $17.23M.
- What is the long-term trend for BridgeBio Pharma's operating lease ROU assets?
- Over 5 years (2020 to 2025), BridgeBio Pharma's operating lease ROU assets has grown at a -13.2% compound annual growth rate (CAGR), from $16.51M to $8.15M.
- What does operating lease ROU assets mean?
- The value of the right to use leased property or equipment over the lease term.
- How do you interpret operating lease ROU assets?
- An increase indicates expansion of leased facilities or longer lease terms, signaling growth or increased operational footprint.
- How does operating lease ROU assets compare across companies?
- Standardized across companies following the adoption of modern lease accounting standards.